Clinical Trial Update: Randomized Controlled Trial of Gemcitabine Combined With 125I Brachytherapy [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating gemcitabine combined with 125I brachytherapy for locally advanced pancreatic cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Gemzar (gemcitabine)

Snippet

Sponsor: Huazhong University of Science and Technology | Conditions: Locally Advanced Pancreatic Cancer | Phase 3 | Status: COMPLETED